The University of Washington’s CoMotion program announced 10 startups that secured UW-licensed intellectual property over the past year. Eight are in healthcare, spanning diagnostic tools, medical devices and new therapeutics. The other two focus on K-12 education or climate change.
CoMotion, which operates as a collaborative innovation hub, reports that it and its predecessors have fostered 310 deep-tech companies over the past three decades, more than one-third of which are still active. Those businesses have raised $1.8 billion from investors in the past five years alone.
Here’s a look at the 10 startups:
CathConnect is a Seattle-based startup making urinary catheters that are easy to insert into a patient’s bladder and will safely disconnect if pulled out accidentally. The devices could help prevent the 450,000 traumatic catheter removals that occur in the U.S. each year, which lead to longer hospital stays, higher medical costs and increased infection risk.
CathConnect was launched by Joelle Tudor, a former UW undergraduate researcher and Michael Malone, a UW doctoral candidate.
Climate Solutions Internationaloffers a software platform that helps government employees analyze factors like climate resilience, cost and carbon emissions for proposed infrastructure projects. The startup is the brainchild ofJan Whittington, a UW urban planning professor who previously received funding from the World Bank to apply these strategies across 300 cities in 30 countries.
Climate Solutions International was selected for CoMotion’s second Climate Tech Incubator, a six-month program located at the Seattle Climate Innovation Hub, a public-private partnership in the city’s downtown.
Colleague AI created an AI tool and chatbots to assist K-12 teachers craft lesson plans and streamline other classroom operations. The technology was developed by Min Sun, a UW professor of education and Colleague AI co-founder, with substantial research and testing by educators.
The UW College of Education was selected two years ago as a national center for research and development on using generative AI as a teaching tool, a designation that included a $10 million grant to support Sun’s work.
DetellaDx is using AI and single-cell technology — a research tool that allows scientists to analyze genetic information in individual cells — to detect early stage cancers with a high degree of accuracy. The diagnostic approach is based on research by Scott Kennedy, an associate professor in the UW Department of Laboratory Medicine & Pathology. DetellaDx’s initial focus is on women with a genetic predisposition for ovarian cancer.
KeenSight Health aims to help clinicians communicate better with patients through its Clinical Intelligence Engine, a coaching software that reviews doctor-patient conversations and gives physicians practical feedback. The platform also incorporates patient history stored in electronic records and other resources.
KeenSight was co-founded by past and current UW professors Dr. Ian Bennett, Dr. Misbah Keen and Larry Mauksch. The startup is based in Bellevue, Wash.
Nanosync Labs has created wearable sensorsthat monitor brain health and sleep without invasive procedures. The devices and platform allow for continuous tracking of changes in brain pressure and deep sleep, a restorative stage essential for brain health. The sensors enable earlier detection of neurological conditions, benefiting patients with traumatic brain injury and sleep disorders.
The technology was developed in the UW lab of Jae-Hyun Chung, an associate professor of mechanical engineering. Viggy Sakthivelpathi, who earned a PhD from the UW, is Nanosync’s co-founder and CEO.
PEAR-Net Society provides resources to help medical and public-health experts understand whether medications, chemicals, infections, vaccines, or other exposures may harm a fetus during pregnancy.
The organization relies on two well-established databases documenting teratogens, factors that can cause birth defects. These include the Teratogen Information System, or TERIS, developed by Dr. Jan Friedman, a UW graduate, and Shepard’s Catalog of Teratogenic Agents.
Precision Cognition Labs has developed a tool for memory assessmentthat can detect mild dysfunction and track changes in cognitive performance. The assessment is faster and easier to use than tools that require in-person, clinical evaluations, allowing for more frequent checkups and longitudinal studies.
The startup is a joint venture between the UW and the University of Groningen in the Netherlands, where it is based. Andrea Stocco, a UW associate professor and expert in computational psychiatry, is a co-founder and scientific director.
Prosthetic Fit 360 is building sensors that improve outcomes for patientswith lower-limb prosthetics. The devices use trilateration, a technology that measures an object’s precise location by calculating distances from multiple known reference points. The startup was founded by Conor Lanahan, who earned his bioengineering and biomedical engineering doctorate degree from the UW.
Skape Bio is using AI to create new therapeuticsthat target G protein-coupled receptors, or GPCRs. The receptors, which are located on cell membranes, detect hormones, neurotransmitters and other signals that trigger biological responses.
The Copenhagen-based startup was founded by Chris Norn in partnership with UW Nobel laureate David Baker and scientists from the UW’s Institute for Protein Design and the BioInnovation Institute in Copenhagen.
Comments are closed, but trackbacks and pingbacks are open.